Clinical Approach to Visual Loss

Comprehensive Practical Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of acute and subacute visual loss

Acute visual loss represents one of the most alarming symptoms a patient can experience and constitutes a neurological emergency requiring rapid evaluation. In the United States, approximately 1 million emergency department visits annually are related to visual complaints, with acute vision loss accounting for a significant proportion. Giant cell arteritis alone, one of the treatable causes, has an incidence of 15 to 25 per 100,000 persons over age 50, and without treatment leads to permanent bilateral blindness in up to 50% of cases. The ability to localize the lesion along the visual pathway and identify time-sensitive diagnoses can mean the difference between sight preservation and irreversible blindness.

Definition

Visual loss refers to a decrease in visual acuity, visual field, or both, resulting from dysfunction at any point along the visual pathway—from the cornea and lens, through the retina and optic nerve, to the optic chiasm, optic tracts, lateral geniculate nucleus, optic radiations, and visual cortex. Acute visual loss develops within minutes to hours, while subacute visual loss evolves over days to weeks. This distinction is critical because it narrows the differential diagnosis and guides urgency of intervention.

Classification by Duration

Category	Duration	Common Causes	Clinical Significance
Transient	Seconds to minutes (less than 24 hours, typically less than 1 hour)	Amaurosis fugax, transient ischemic attack, papilledema-related obscurations, ocular migraine	Warning sign of impending stroke or permanent vision loss; requires urgent vascular workup
Acute	Minutes to hours (less than 72 hours)	Central retinal artery occlusion, ischemic optic neuropathy, retinal detachment, vitreous hemorrhage, acute angle-closure glaucoma	Ophthalmological and neurological emergency; many causes are time-sensitive with narrow treatment windows
Subacute	Days to weeks (72 hours to 4 weeks)	Optic neuritis, compressive optic neuropathy, giant cell arteritis, posterior ischemic optic neuropathy	Suggests inflammatory, demyelinating, or compressive etiology; allows time for systematic workup but still urgent

Classification by Laterality

Monocular Visual Loss

Localization: The lesion is anterior to the optic chiasm—involving the eye itself (cornea, lens, vitreous, retina) or the optic nerve.

Key causes: Central retinal artery occlusion, central retinal vein occlusion, ischemic optic neuropathy, optic neuritis, retinal detachment, vitreous hemorrhage, acute glaucoma.

Clinical implication: Monocular involvement immediately localizes the pathology and guides examination toward ocular and optic nerve structures.

Binocular Visual Loss

Localization: The lesion is at or posterior to the optic chiasm—involving the chiasm itself, optic tracts, lateral geniculate nucleus, optic radiations, or visual cortex.

Key causes: Chiasmal compression (pituitary adenoma), stroke affecting visual cortex, bilateral optic neuropathy (toxic, nutritional), posterior reversible encephalopathy syndrome.

Clinical implication: Binocular symptoms require neuroimaging and consideration of central nervous system pathology.

Classification by Visual Field Pattern

Pattern	Description	Localizes To	Classic Causes
Complete monocular blindness	Total vision loss in one eye	Optic nerve or entire retina	Central retinal artery occlusion, severe optic neuritis, complete optic nerve infarction
Central scotoma	Loss of central vision with preserved peripheral vision	Macula or papillomacular bundle	Optic neuritis, macular degeneration, central serous retinopathy
Altitudinal defect	Loss of upper or lower half of visual field, respecting horizontal meridian	Optic nerve (vascular supply territory)	Anterior ischemic optic neuropathy, branch retinal artery occlusion
Bitemporal hemianopia	Loss of temporal fields bilaterally	Optic chiasm	Pituitary adenoma, craniopharyngioma, meningioma
Homonymous hemianopia	Loss of same side of visual field in both eyes (e.g., right field in both eyes)	Contralateral optic tract, lateral geniculate nucleus, optic radiations, or visual cortex	Stroke, tumor, hemorrhage affecting post-chiasmal pathway
Homonymous quadrantanopia	Loss of one quadrant of visual field in both eyes	Optic radiations (temporal lobe = superior quadrant; parietal lobe = inferior quadrant)	Stroke, tumor affecting optic radiations

Classification by Onset Pattern

Onset Pattern	Description	Suggests
Sudden and maximal at onset	Vision loss is complete or near-complete from the first moment	Vascular occlusion (central retinal artery occlusion, anterior ischemic optic neuropathy), retinal detachment
Progressive over hours	Vision worsens steadily over several hours	Evolving vascular event, acute angle-closure glaucoma, vitreous hemorrhage
Progressive over days	Gradual decline over 1 to 14 days	Optic neuritis (typically progresses over 1 to 2 weeks then stabilizes), giant cell arteritis
Fluctuating	Vision varies throughout the day or with position	Papilledema (visual obscurations), intermittent angle closure, dry eye
Stepwise deterioration	Discrete episodes of worsening with stable periods between	Recurrent ischemic events, progressive giant cell arteritis

Key Concept: The “Big Five” Emergencies

Five diagnoses must be considered immediately in any patient with acute visual loss because delayed treatment leads to permanent blindness:

Central retinal artery occlusion — treatment window of 90 to 120 minutes for potential vision salvage
Giant cell arteritis — without treatment, fellow eye involvement occurs in 50% within days
Acute angle-closure glaucoma — intraocular pressure must be lowered within hours
Retinal detachment — surgical repair within 24 hours if macula is attached
Pituitary apoplexy — hemorrhage or infarction of pituitary adenoma, may require emergent surgical decompression

Impact and Urgency

Why Urgent Evaluation Matters

Visual loss has profound implications beyond the eye itself:

Stroke warning: Amaurosis fugax carries a 2% to 8% annual stroke risk; central retinal artery occlusion is considered a “stroke equivalent”
Systemic disease marker: Giant cell arteritis causes blindness but also aortic aneurysm; optic neuritis may herald multiple sclerosis
Bilateral risk: Untreated giant cell arteritis leads to fellow eye blindness in up to 50% of patients within 1 to 2 weeks
Narrow treatment windows: Central retinal artery occlusion has a 90-minute window similar to acute stroke; delays are irreversible

2. Pathophysiology and Mechanisms

Understanding the visual pathway and mechanisms of visual loss

The visual system is an elegantly organized pathway that transforms light into conscious perception. Understanding this anatomy is essential because the pattern of visual loss directly localizes the lesion. A systematic knowledge of the visual pathway—from the retina through the optic nerve, chiasm, tracts, radiations, and cortex—allows the clinician to predict which structures are affected based on the visual field defect and associated findings.

The Visual Pathway

Structure	Anatomy	Function	Lesion Produces
Retina	Photoreceptors (rods and cones), bipolar cells, ganglion cells; fovea is area of highest acuity	Phototransduction—converts light to electrical signals; ganglion cell axons form the optic nerve	Monocular visual loss; pattern depends on area affected (central, peripheral, or sectoral)
Optic nerve	Approximately 1.2 million ganglion cell axons; divided into intraocular (optic disc), intraorbital, intracanalicular, and intracranial segments	Transmits visual information from retina to chiasm; papillomacular bundle carries central vision fibers	Monocular visual loss, often with relative afferent pupillary defect; central scotoma if papillomacular bundle affected
Optic chiasm	Located above the pituitary gland; nasal retinal fibers (temporal visual field) cross here	Allows binocular visual field representation in each hemisphere; nasal fibers decussate, temporal fibers remain ipsilateral	Bitemporal hemianopia (classic); may be asymmetric depending on compression location
Optic tract	Extends from chiasm to lateral geniculate nucleus; contains ipsilateral temporal and contralateral nasal retinal fibers	Carries visual information representing the contralateral visual field	Incongruous homonymous hemianopia (fibers not yet fully organized); relative afferent pupillary defect contralateral to lesion
Lateral geniculate nucleus	Thalamic relay station; six-layered structure with precise retinotopic organization	Processes and relays visual information to visual cortex; also receives input from brainstem for circadian rhythm	Congruous homonymous hemianopia; rare in isolation (usually involves adjacent structures)
Optic radiations	Fan out from lateral geniculate nucleus through temporal and parietal lobes to visual cortex; Meyer’s loop (inferior fibers) passes through temporal lobe	Final relay to visual cortex; superior fibers through parietal lobe, inferior fibers through temporal lobe (Meyer’s loop)	Homonymous quadrantanopia—”pie in the sky” (temporal lobe, Meyer’s loop) or “pie on the floor” (parietal lobe)
Primary visual cortex (V1)	Brodmann area 17, located in calcarine sulcus of occipital lobe; macular representation at occipital pole	Conscious visual perception; processes edges, orientation, movement; macular sparing may occur due to dual blood supply	Highly congruous homonymous hemianopia, often with macular sparing; cortical blindness if bilateral

Blood Supply to the Visual Pathway

Retina and Optic Nerve Head

Central retinal artery: Branch of ophthalmic artery; supplies inner retinal layers

Posterior ciliary arteries: Supply optic nerve head and outer retina (choroid)

Clinical relevance: Central retinal artery occlusion causes inner retinal infarction with “cherry red spot”; anterior ischemic optic neuropathy results from posterior ciliary artery insufficiency

Optic Nerve and Chiasm

Ophthalmic artery: Supplies orbital optic nerve

Internal carotid artery branches: Supply intracranial optic nerve and chiasm

Clinical relevance: Carotid stenosis can cause ocular ischemic syndrome; chiasmal apoplexy occurs with pituitary adenoma hemorrhage

Retrochiasmal Pathway

Posterior cerebral artery: Supplies visual cortex; occlusion causes homonymous hemianopia with macular sparing

Middle cerebral artery: Supplies optic radiations; occlusion causes hemianopia with associated hemispheric signs

Clinical relevance: Macular sparing suggests posterior cerebral artery territory stroke (dual blood supply to occipital pole)

How Conditions Cause Visual Loss

Condition	Mechanism	Why This Matters Clinically
Central retinal artery occlusion	Embolic or thrombotic occlusion of central retinal artery causes inner retinal ischemia; outer retina survives via choroidal circulation, creating the “cherry red spot” at fovea	Treatment window is 90 to 120 minutes (similar to stroke); requires immediate workup for embolic source (carotid, cardiac); consider intra-arterial thrombolysis in select cases
Anterior ischemic optic neuropathy (arteritic)	Giant cell arteritis causes granulomatous vasculitis of posterior ciliary arteries, leading to optic nerve head infarction; inflammation is segmental and “skip lesions” occur	Medical emergency—immediate high-dose corticosteroids to prevent fellow eye involvement; erythrocyte sedimentation rate and C-reactive protein are elevated but may be normal in 5% of cases
Anterior ischemic optic neuropathy (non-arteritic)	Presumed hypoperfusion of posterior ciliary arteries in patients with “disc at risk” (small cup-to-disc ratio); often occurs with nocturnal hypotension	No proven treatment; associated with vascular risk factors; 15% risk of fellow eye involvement over 5 years
Optic neuritis	Inflammatory demyelination of optic nerve; T-cell mediated attack on myelin disrupts axonal conduction; may be associated with multiple sclerosis, neuromyelitis optica, or be idiopathic	Intravenous corticosteroids speed recovery but do not change final outcome; MRI brain determines risk of multiple sclerosis; aquaporin-4 and myelin oligodendrocyte glycoprotein antibody testing if atypical features
Retinal detachment	Separation of neurosensory retina from retinal pigment epithelium deprives photoreceptors of metabolic support; vitreous fluid enters subretinal space through retinal break	Surgical emergency if macula is attached (better visual prognosis); urgent repair within 24 hours improves outcomes
Acute angle-closure glaucoma	Pupillary block prevents aqueous outflow; intraocular pressure rises to 40 to 80 mmHg, causing optic nerve ischemia and corneal edema	Requires immediate pressure-lowering with topical and systemic agents; laser peripheral iridotomy is definitive treatment
Occipital stroke	Posterior cerebral artery occlusion causes infarction of primary visual cortex; macular sparing occurs because occipital pole receives collateral supply from middle cerebral artery	Associated with vertebrobasilar disease; patients may have “macular sparing” hemianopia and be unaware of deficit (visual anosognosia)
Pituitary apoplexy	Hemorrhage or infarction within pituitary adenoma causes rapid expansion, compressing optic chiasm from below	Neurosurgical emergency; presents with headache, ophthalmoplegia, and bitemporal field defects; requires urgent decompression if visual loss is progressive
Posterior reversible encephalopathy syndrome	Vasogenic edema predominantly affecting posterior cerebral regions due to failure of cerebral autoregulation; associated with hypertension, eclampsia, immunosuppression	Visual loss is typically reversible with blood pressure control and removal of offending agent; cortical blindness may be complete

The Pupillary Light Reflex Pathway

Understanding the pupillary pathway is essential because the relative afferent pupillary defect (Marcus Gunn pupil) is a critical localizing sign that indicates optic nerve dysfunction ipsilateral to the affected eye.

Component	Structure	Clinical Relevance
Afferent limb	Retinal ganglion cells → optic nerve → partial decussation at chiasm → optic tract → pretectal nucleus (midbrain)	Damage to optic nerve causes relative afferent pupillary defect (RAPD)—the affected pupil dilates with direct light (due to reduced afferent input) but constricts with consensual light
Integration	Pretectal nucleus sends bilateral projections to Edinger-Westphal nuclei	Bilateral input explains why consensual response is preserved in optic nerve lesions
Efferent limb	Edinger-Westphal nucleus → oculomotor nerve → ciliary ganglion → short ciliary nerves → pupillary sphincter	Third nerve palsy causes dilated, unreactive pupil; ciliary ganglion damage (tonic pupil) causes light-near dissociation

Critical Teaching Point: The relative afferent pupillary defect (RAPD) is the single most important sign distinguishing optic nerve disease from macular disease. Both can cause severe visual loss, but only optic nerve dysfunction produces a RAPD. Retinal disease must be extensive (greater than 50% of retina affected) to produce a detectable RAPD.

Often Overlooked Mechanism: Functional Visual Loss

Functional (non-organic) visual loss accounts for up to 5% of patients presenting to neuro-ophthalmology clinics. It is a diagnosis of exclusion but has characteristic examination findings:

Normal pupillary responses (no RAPD) despite reported severe unilateral vision loss
Normal optic nerve appearance and normal optical coherence tomography
“Tunnel vision” that does not expand with distance (organic tunnel vision expands proportionally)
Variable visual acuity on repeated testing
Preserved optokinetic nystagmus when large moving targets are presented

Recognizing functional visual loss prevents unnecessary investigations and allows appropriate management, including reassurance that structural vision is intact.

Localizing Lesions by Visual Field Defect

Visual Field Defect	Lesion Location	Key Associated Findings
Monocular central scotoma	Optic nerve (papillomacular bundle) or macula	RAPD if optic nerve; normal pupil if purely macular
Monocular altitudinal defect	Optic nerve (anterior ischemic optic neuropathy) or branch retinal artery occlusion	Disc edema (if anterior ischemic optic neuropathy); visible retinal infarct (if arterial)
Junctional scotoma	Junction of optic nerve and chiasm	Ipsilateral central scotoma + contralateral superior temporal defect (Wilbrand’s knee)
Bitemporal hemianopia	Optic chiasm	Endocrine abnormalities if pituitary adenoma; headache if apoplexy
Homonymous hemianopia (incongruous)	Optic tract	RAPD contralateral to lesion; “bow-tie” optic atrophy develops later
Homonymous hemianopia (congruous)	Lateral geniculate nucleus, optic radiations, or visual cortex	No RAPD; associated hemispheric signs depend on location
Superior homonymous quadrantanopia	Temporal lobe (Meyer’s loop)	May have memory impairment, auditory symptoms, or seizures
Inferior homonymous quadrantanopia	Parietal lobe	May have hemisensory loss, neglect, or apraxia
Homonymous hemianopia with macular sparing	Occipital cortex (posterior cerebral artery territory)	Suggests vascular etiology; patient may be unaware of deficit

3. History Taking

A comprehensive approach to eliciting the visual loss history

Red Flags — Require Urgent Evaluation

Sudden painless monocular vision loss — central retinal artery occlusion, ischemic optic neuropathy
Age over 50 with new headache — giant cell arteritis until proven otherwise
Jaw claudication or scalp tenderness — highly specific for giant cell arteritis
Eye pain with nausea and vomiting — acute angle-closure glaucoma
Flashing lights followed by “curtain” over vision — retinal detachment

Transient vision loss (amaurosis fugax) — carotid stenosis, cardiac embolism, impending central retinal artery occlusion
Bilateral vision loss with headache — pituitary apoplexy, posterior reversible encephalopathy syndrome, bilateral occipital stroke
Vision loss with diplopia and ptosis — pituitary apoplexy with cavernous sinus involvement
Progressive vision loss over days with pain on eye movement — optic neuritis (may indicate multiple sclerosis)
Recent polymyalgia rheumatica symptoms — up to 50% association with giant cell arteritis

Systematic History: The “VISION” Approach

Use the mnemonic “VISION” to ensure comprehensive history taking:

V — Velocity of onset: Sudden (seconds to minutes) suggests vascular; gradual (days) suggests inflammatory or compressive. Ask: “Did you wake up with it, or did it come on while you were awake? Over seconds, minutes, hours, or days?”
I — Ipsilateral or bilateral: Monocular localizes anterior to chiasm; binocular suggests chiasmal or retrochiasmal pathology. Ask: “If you cover one eye, then the other, is the vision loss in one eye or both?”
S — Site of field loss: Central, peripheral, altitudinal, or hemianopic? Ask: “Is it the center of your vision, the sides, the top, the bottom, or everything?”
I — Inflammatory and ischemic symptoms: Pain suggests inflammation (optic neuritis) or ischemia (giant cell arteritis, acute glaucoma). Ask: “Do you have any pain? Does it hurt to move your eyes? Any headache, jaw pain when chewing, or scalp tenderness?”
O — Other neurological symptoms: Weakness, numbness, ataxia, or speech changes suggest stroke or demyelination. Ask: “Have you noticed any weakness, numbness, difficulty walking, or trouble speaking?”
N — Negative and positive phenomena: Negative (scotoma, blackout) suggests structural; positive (flashes, zigzags) suggests retinal traction or migraine. Ask: “Did you see flashing lights, zigzag lines, or was it just darkness or blur?”

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Central retinal artery occlusion	Sudden, painless, complete monocular vision loss; “like a shade coming down”	“Did the vision loss come on all at once, within seconds? Was there any warning or did it just happen suddenly?”
Giant cell arteritis	Age over 50, new headache, jaw claudication, scalp tenderness, polymyalgia symptoms, constitutional symptoms	“Do you get pain in your jaw muscles when you chew that goes away when you rest? Have you had any new headaches, tenderness when you comb your hair, or unexplained weight loss or fevers?”
Non-arteritic anterior ischemic optic neuropathy	Sudden painless vision loss on awakening, altitudinal field defect, vascular risk factors	“Did you notice the vision loss when you first woke up in the morning? Do you have high blood pressure, diabetes, or sleep apnea?”
Optic neuritis	Subacute vision loss over days, pain with eye movement, age 20 to 50, may have prior neurological symptoms	“Does it hurt when you move your eyes, especially looking up or to the side? Has the vision gotten progressively worse over the past few days? Have you ever had numbness, tingling, or weakness in your arms or legs?”
Retinal detachment	Photopsias followed by “floaters” then “curtain” or “shadow”; often in myopes or after trauma	“Did you see flashing lights first, then a lot of new floaters, and then a shadow or curtain coming across your vision? Are you very nearsighted? Any recent eye injury or surgery?”
Acute angle-closure glaucoma	Severe eye pain, headache, nausea, vomiting, halos around lights, red eye	“Is your eye very painful? Are you seeing colored halos around lights? Have you been vomiting? Did this start in a dark room or after taking any new medications?”
Vitreous hemorrhage	Sudden onset of floaters, “cobwebs,” or diffuse haziness; history of diabetes or trauma	“Did you suddenly see a lot of floaters or cobwebs, or did everything become hazy like looking through smoke? Do you have diabetes? Any recent eye procedures or injury?”
Amaurosis fugax	Transient monocular vision loss lasting seconds to minutes, complete recovery	“How long did the vision loss last—seconds, minutes, or longer? Did it come back completely to normal? Has it happened before? Do you have atrial fibrillation or have you had a TIA or stroke?”
Occipital stroke	Sudden homonymous hemianopia, may be unaware of deficit, headache with vertebrobasilar dissection	“Have you bumped into things on one side? Did anyone notice you ignoring things on one side? Any recent neck pain, chiropractic manipulation, or trauma?”
Pituitary apoplexy	Severe sudden headache, bitemporal field loss, diplopia, known pituitary adenoma	“Did you have a sudden severe headache? Are you seeing double? Have you been told you have a pituitary tumor? Any recent changes in your energy, libido, or menstrual periods?”
Posterior reversible encephalopathy syndrome	Bilateral vision loss, headache, confusion, seizures, hypertension, recent immunosuppression	“Have you had very high blood pressure recently? Are you taking any immunosuppressive medications like cyclosporine or tacrolimus? Have you been pregnant or recently delivered? Any seizures?”

Temporal Pattern Analysis

Pattern	Duration	Most Likely Diagnosis	Key Differentiating Question
Transient monocular	Seconds to minutes	Amaurosis fugax (embolic), papilledema-related obscurations	“Did vision black out completely then return? Does it happen when you change position or cough?”
Transient binocular	Minutes to 1 hour	Migraine with aura, vertebrobasilar transient ischemic attack	“Did you see zigzag lines or shimmering? Was it followed by headache? Any dizziness or vertigo with it?”
Sudden persistent monocular	Immediate and lasting	Central retinal artery occlusion, ischemic optic neuropathy, retinal detachment	“Has vision returned at all since it happened? Any flashes or floaters beforehand?”
Progressive over days (monocular)	1 to 14 days	Optic neuritis, compressive optic neuropathy	“Is it still getting worse, or has it stabilized? Any pain with eye movement?”
Sudden persistent binocular	Immediate and lasting	Bilateral occipital stroke, pituitary apoplexy	“Can you see anything at all? Any severe headache when it started?”

Medication and Risk Factor History

Medications Associated with Visual Loss

Ethambutol — optic neuropathy (dose-dependent, screen monthly)
Amiodarone — optic neuropathy (rare but severe)
Phosphodiesterase-5 inhibitors — non-arteritic anterior ischemic optic neuropathy
Vigabatrin — irreversible peripheral field constriction
Hydroxychloroquine — macular toxicity (bull’s eye maculopathy)
Tamoxifen — crystalline retinopathy, macular edema
Topiramate — acute angle-closure glaucoma (idiosyncratic)
Anticholinergics — precipitate angle closure in predisposed eyes
Corticosteroids — cataracts, glaucoma (chronic use)

Vascular Risk Factors to Assess

Hypertension — retinal vascular disease, ischemic optic neuropathy, posterior reversible encephalopathy syndrome
Diabetes mellitus — diabetic retinopathy, vitreous hemorrhage, ischemic optic neuropathy
Hyperlipidemia — atherosclerotic disease, embolic risk
Atrial fibrillation — cardioembolic central retinal artery occlusion, stroke
Carotid stenosis — amaurosis fugax, central retinal artery occlusion, ocular ischemic syndrome
Sleep apnea — non-arteritic anterior ischemic optic neuropathy (nocturnal hypotension)
Smoking — all vascular causes
Hypercoagulable states — retinal vein and artery occlusions

Relevant Past Medical and Ocular History

History Element	Relevance	Specific Conditions to Ask About
Prior episodes of vision loss	Recurrent optic neuritis suggests multiple sclerosis or neuromyelitis optica spectrum disorder	“Have you ever had vision loss in either eye before? Did it recover?”
History of neurological symptoms	Prior episodes of numbness, weakness, or bladder dysfunction suggest demyelinating disease	“Have you ever had episodes of numbness, weakness, difficulty walking, or bladder problems that came and went?”
Autoimmune diseases	Systemic lupus erythematosus, sarcoidosis, and other conditions can cause optic neuropathy	“Do you have lupus, sarcoidosis, or any autoimmune condition?”
Cancer history	Paraneoplastic optic neuropathy, metastatic compression, radiation optic neuropathy	“Have you ever had cancer? Have you received radiation to the head or neck?”
Refractive status	High myopia is a risk factor for retinal detachment; hyperopia for angle closure	“Are you very nearsighted or farsighted? What is your glasses prescription?”
Prior eye surgery or trauma	Increases risk of retinal detachment, endophthalmitis, sympathetic ophthalmia	“Have you had any eye surgery, including LASIK or cataract surgery? Any eye injuries?”
Family history	Leber hereditary optic neuropathy (maternally inherited), glaucoma, macular degeneration	“Does anyone in your family have vision problems, especially optic nerve disease or glaucoma?”

Social and Exposure History

Toxic and Nutritional Exposures

Alcohol abuse — toxic optic neuropathy, Wernicke encephalopathy
Tobacco — tobacco-alcohol amblyopia, vascular disease
Methanol ingestion — severe bilateral optic neuropathy (emergency)
Nutritional deficiency — vitamin B12, folate, thiamine deficiency optic neuropathy
Illicit drugs — talc retinopathy (intravenous drug use), cocaine-induced vasospasm

Infectious Risk Assessment

HIV status — cytomegalovirus retinitis, cryptococcal meningitis with papilledema
Tuberculosis exposure — tuberculous optic neuropathy, choroiditis
Syphilis risk factors — syphilitic optic neuritis, uveitis
Cat exposure — Bartonella neuroretinitis
Tick exposure — Lyme optic neuritis

4. Physical Examination

A systematic approach for evaluating acute and subacute visual loss

Systematic Framework: Use the “Eyes First, Then the Rest” approach. Begin with a complete ocular examination to localize the lesion, then perform targeted neurological and systemic examinations based on your findings. The key question is: Is this an eye problem, an optic nerve problem, or a brain problem?

Visual Acuity Assessment

The Most Important Measurement

Visual acuity is the “vital sign” of the eye. Always document acuity in each eye separately, with the patient’s glasses or through a pinhole (which corrects refractive error).

Snellen chart: Standard measurement (20/20 is normal; 20/200 is legal blindness)
Pinhole acuity: If acuity improves with pinhole, the problem is refractive (not neurological)
Count fingers, hand motion, light perception: Use when acuity is too poor for chart
No light perception: Complete blindness in that eye

Pupillary Examination

The pupillary examination is critical for distinguishing optic nerve disease from retinal or macular disease. The swinging flashlight test for relative afferent pupillary defect (RAPD) is the single most important bedside test.

Test	Technique	Findings and Interpretation
Direct light reflex	Shine light in one eye, observe that pupil’s response	Absent: efferent defect (third nerve) or severe afferent defect
Consensual light reflex	Shine light in one eye, observe opposite pupil’s response	Tests crossover at pretectal nucleus; absent with efferent defect on contralateral side
Swinging flashlight test (RAPD)	Swing light between eyes every 2 to 3 seconds; observe for pupil dilation when light moves to affected eye	RAPD present: When light shines in affected eye, both pupils dilate (less afferent input). Indicates optic nerve disease ipsilateral to the RAPD. A RAPD is NOT caused by media opacity, macular disease (unless extensive), or refractive error.
Near response	Have patient look at distant target, then at near target; observe pupil constriction	Light-near dissociation (pupils react to near but not light): Argyll Robertson pupils (neurosyphilis), tonic pupil
Pupil size and shape	Measure in dim and bright light; note irregularity	Dilated and fixed: acute angle closure, third nerve palsy. Irregular: prior inflammation, trauma, surgery

RAPD Interpretation Pearl

The presence of a RAPD with visual loss = optic nerve disease until proven otherwise. The absence of a RAPD in a patient with monocular visual loss suggests the problem is anterior to the retinal ganglion cells (media opacity, macular disease) or is functional. Bilateral symmetric optic nerve disease will NOT produce a RAPD because both sides are equally affected.

Visual Field Testing at the Bedside

Test	Technique	What It Detects
Confrontation fields	Patient covers one eye; examiner presents fingers in each quadrant; patient counts fingers	Gross hemianopia, quadrantanopia; may miss subtle defects
Red desaturation	Present red target in each quadrant and across vertical meridian; ask “Is the red equally bright everywhere?”	Subtle optic nerve dysfunction (red appears “washed out” or “pink” in affected field)
Central scotoma testing	Patient fixates on examiner’s nose; examiner moves finger from periphery toward fixation; “Tell me when you see my finger”	Central or paracentral scotoma (finger disappears near fixation)
Amsler grid	Patient views grid at 30 cm with one eye; reports missing, distorted, or wavy lines	Macular disease (metamorphopsia), central scotoma
Finger counting in quadrants	Hold up 1 to 5 fingers in each quadrant; patient identifies number	Quantifies defect severity; detects homonymous defects

External and Anterior Segment Examination

Structure	What to Examine	Findings and Significance
Eyelids and orbit	Proptosis, lid position, injection	Proptosis: orbital mass, thyroid eye disease, cavernous sinus pathology. Ptosis: third nerve palsy, Horner syndrome
Conjunctiva	Injection pattern (ciliary vs. conjunctival)	Ciliary flush (perilimbal injection): acute angle closure, uveitis. Diffuse injection: conjunctivitis (usually not vision-threatening)
Cornea	Clarity, edema, epithelial defects	Corneal edema: acute angle closure (hazy cornea). Epithelial defects: exposure keratopathy, herpes simplex keratitis
Anterior chamber	Depth, cells, flare, hypopyon, hyphema	Shallow chamber: angle closure. Cells and flare: uveitis. Hypopyon: severe uveitis, endophthalmitis
Lens	Clarity, position	Cataract: gradual vision loss. Subluxed lens: Marfan syndrome, trauma, can cause acute glaucoma

Intraocular Pressure

Measurement Methods

Tonometry (Goldmann, Tono-Pen): Gold standard; normal 10 to 21 mmHg
Tactile estimation: Press gently on closed eye through lid; very elevated pressure feels “rock hard” (useful if no tonometer)

Clinical Significance

Greater than 40 mmHg: Acute angle-closure glaucoma until proven otherwise
Very low pressure: Hypotony from penetrating trauma, post-surgical leak
Asymmetry greater than 5 mmHg: May indicate unilateral glaucoma or ocular ischemic syndrome

Funduscopic Examination

Direct ophthalmoscopy should be performed in every patient with visual loss. Dilate the pupil if not contraindicated (avoid if acute angle closure suspected or neurological observation needed).

Optic Disc Findings

Finding	Description	Associated Conditions
Disc edema (swelling)	Blurred disc margins, hyperemia, obscured vessels at disc margin, loss of venous pulsations	Anterior ischemic optic neuropathy, papillitis (optic neuritis), papilledema, central retinal vein occlusion
Pale disc (optic atrophy)	White or gray disc with sharp margins, reduced capillarity	Prior optic neuritis, prior ischemic optic neuropathy, compressive optic neuropathy, hereditary optic neuropathy
Disc pallor with edema	Chalky white swollen disc	Arteritic anterior ischemic optic neuropathy (giant cell arteritis)—the “pale disc with edema” is classic
Sectoral disc edema	Edema affecting only superior or inferior portion of disc	Non-arteritic anterior ischemic optic neuropathy (altitudinal defect corresponds to opposite field)
Cupping (increased cup-to-disc ratio)	Enlarged central cup with thin neuroretinal rim	Glaucoma (chronic); acute glaucoma may not show cupping initially
Disc hemorrhage	Flame-shaped hemorrhage at disc margin	Glaucoma (prognostic sign), papilledema, anterior ischemic optic neuropathy
Crowded disc (“disc at risk”)	Small disc with minimal cup (cup-to-disc ratio less than 0.2)	Risk factor for non-arteritic anterior ischemic optic neuropathy; check fellow eye
Normal disc	Pink rim, distinct margins, normal cup, visible venous pulsations	Retrobulbar optic neuritis (disc normal initially), macular disease, posterior pathway lesions

Retinal Findings

Finding	Description	Associated Conditions
Cherry red spot	Red fovea surrounded by pale, edematous retina	Central retinal artery occlusion (the fovea appears red because it is thin and the choroidal circulation shows through)
Box-car segmentation of vessels	Interrupted column of blood in retinal arteries	Central retinal artery occlusion, branch retinal artery occlusion
Retinal whitening	Pale, opaque retina in distribution of occluded vessel	Retinal artery occlusion (inner retinal infarction)
Dilated tortuous veins with hemorrhages	“Blood and thunder” appearance with flame hemorrhages, cotton wool spots	Central retinal vein occlusion
Retinal detachment	Elevated, undulating retina; may see retinal tear	Rhegmatogenous retinal detachment (with tear), exudative or tractional detachment
Vitreous hemorrhage	Blood in vitreous cavity; may obscure fundus view	Proliferative diabetic retinopathy, posterior vitreous detachment with retinal tear, trauma
Macular abnormalities	Drusen, hemorrhage, edema, scar	Age-related macular degeneration, diabetic macular edema, central serous chorioretinopathy
Hollenhorst plaque	Refractile yellow-orange plaque at arteriolar bifurcation	Cholesterol embolus from carotid plaque; marker for systemic atherosclerosis

Ocular Motility Examination

Finding	Pattern	Conditions to Consider
Third nerve palsy	Ptosis, “down and out” eye position, dilated pupil (if complete)	Pituitary apoplexy, posterior communicating artery aneurysm, uncal herniation
Sixth nerve palsy	Limited abduction, esotropia in primary gaze	Elevated intracranial pressure (false localizing sign), cavernous sinus pathology
Internuclear ophthalmoplegia	Impaired adduction with nystagmus of abducting eye	Multiple sclerosis (bilateral), stroke (unilateral)
Gaze palsy	Cannot look in one direction with either eye	Frontal or brainstem stroke
Pain with eye movement	Pain on upgaze or lateral gaze, especially with optic neuritis	Optic neuritis (90% have pain with eye movement), orbital inflammatory disease

Targeted Neurological Examination

System	What to Assess	Relevance to Visual Loss
Mental status	Alertness, orientation, attention	Confusion with visual loss: posterior reversible encephalopathy syndrome, bilateral occipital strokes, encephalitis
Cranial nerves III, IV, VI	Ocular motility, pupil responses, ptosis	Combined visual loss and ophthalmoplegia: pituitary apoplexy, cavernous sinus lesion
Cranial nerve V	Facial sensation	Numbness with visual loss: cavernous sinus pathology
Motor examination	Hemiparesis, pronator drift	Hemianopia with hemiparesis: stroke affecting middle cerebral artery territory
Sensory examination	Hemisensory loss	Hemianopia with hemisensory loss: thalamic or parietal stroke
Cerebellar examination	Ataxia, dysmetria, nystagmus	Visual loss with ataxia: vertebrobasilar stroke, multiple sclerosis
Reflexes	Deep tendon reflexes, Babinski sign	Hyperreflexia, Babinski: upper motor neuron lesion (stroke, demyelination)

Systemic Examination for Visual Loss

Cardiovascular

Blood pressure: Severe hypertension suggests posterior reversible encephalopathy syndrome or hypertensive retinopathy
Heart rhythm: Irregular pulse suggests atrial fibrillation (embolic risk)
Carotid bruits: Suggests carotid stenosis (amaurosis fugax, central retinal artery occlusion risk)
Cardiac murmurs: May indicate valvular disease with embolic potential

Head and Neck

Temporal arteries: Tenderness, thickening, reduced pulsation, nodularity in giant cell arteritis
Scalp tenderness: Diffuse scalp tenderness in giant cell arteritis
Jaw claudication test: Have patient chew repetitively; pain suggests giant cell arteritis
Neck stiffness: Meningitis with papilledema, subarachnoid hemorrhage

Expected Findings by Etiology

Condition	Visual Acuity	RAPD	Disc Appearance	Other Key Findings
Central retinal artery occlusion	Counting fingers to light perception	Present	Normal initially; later pallor	Cherry red spot, pale retina, box-car vessels
Arteritic anterior ischemic optic neuropathy	Counting fingers to no light perception	Present	Pale edema (“chalky white”)	Tender temporal arteries, elevated erythrocyte sedimentation rate
Non-arteritic anterior ischemic optic neuropathy	Variable (20/40 to counting fingers)	Present	Sectoral or diffuse edema	Altitudinal field defect, “disc at risk” in fellow eye
Optic neuritis	20/40 to light perception	Present	Normal (retrobulbar) or mild edema (papillitis)	Pain with eye movement, dyschromatopsia
Acute angle-closure glaucoma	Reduced (edema)	May be present	May have disc edema	Rock-hard eye, mid-dilated fixed pupil, corneal edema, ciliary flush, intraocular pressure greater than 40 mmHg
Retinal detachment	Variable (depends on macula status)	May be present if extensive	May be difficult to see	Elevated retina on funduscopy, relative field defect opposite detachment
Central retinal vein occlusion	20/40 to counting fingers	Present if ischemic type	Edema, hemorrhages	“Blood and thunder” fundus, dilated tortuous veins
Occipital stroke	Normal (for central acuity)	Absent	Normal	Homonymous hemianopia (often macular sparing), normal pupil responses
Pituitary apoplexy	Variable	May be bilateral	Normal or pale	Bitemporal hemianopia, ophthalmoplegia, severe headache

Important Teaching Point

Normal fundus examination does NOT exclude serious pathology!

Retrobulbar optic neuritis: The disc is normal because inflammation is behind the eye (“the patient sees nothing, and the doctor sees nothing”)
Early central retinal artery occlusion: Retinal changes may take 1 to 2 hours to develop
Posterior pathway lesions: Optic tract, lateral geniculate nucleus, optic radiations, and occipital cortex lesions produce hemianopia with a completely normal fundus
Posterior ischemic optic neuropathy: Disc appears normal; rare but occurs with giant cell arteritis or perioperative hypotension

If the history strongly suggests serious pathology but the examination is normal, proceed with urgent imaging and laboratory investigation.

5. Differential Diagnosis

Systematic approach organized by probability, duration, and anatomical location

Acute Monocular Visual Loss (Minutes to Hours)

Probability	Condition	Key Features	Red Flags
COMMON (approximately 60%)	Retinal vascular occlusion (central retinal artery occlusion, branch retinal artery occlusion, central retinal vein occlusion)	Sudden painless vision loss; central retinal artery occlusion: complete loss with cherry red spot; central retinal vein occlusion: “blood and thunder” fundus	Central retinal artery occlusion is stroke equivalent—90-minute treatment window; screen for giant cell arteritis in age over 50
COMMON	Anterior ischemic optic neuropathy (arteritic and non-arteritic)	Sudden painless vision loss, often on awakening; altitudinal field defect; disc edema	Age over 50 with headache, jaw claudication, scalp tenderness = giant cell arteritis until proven otherwise
COMMON	Vitreous hemorrhage	Sudden floaters, “cobwebs,” hazy vision; history of diabetes, trauma, or posterior vitreous detachment	May indicate underlying retinal tear or detachment—requires urgent fundus examination
LESS COMMON (approximately 25%)	Retinal detachment	Photopsias, floaters, then “curtain” or shadow; myopia, prior cataract surgery, trauma	Macula-on detachment = surgical emergency within 24 hours
LESS COMMON	Acute angle-closure glaucoma	Severe eye pain, headache, nausea, halos around lights; mid-dilated fixed pupil; rock-hard eye	Intraocular pressure greater than 40 mmHg; requires immediate pressure-lowering treatment
UNCOMMON BUT SERIOUS (approximately 15%)	Giant cell arteritis (arteritic anterior ischemic optic neuropathy)	Age over 50, new headache, jaw claudication, polymyalgia symptoms; chalky pale disc edema	50% risk of fellow eye involvement without treatment; start corticosteroids immediately
UNCOMMON BUT SERIOUS	Ophthalmic artery occlusion	Complete monocular blindness, no cherry red spot (entire retina pale), no light perception	More severe than central retinal artery occlusion; worse prognosis; same embolic workup required

Subacute Monocular Visual Loss (Days to Weeks)

Step-by-Step Approach to Subacute Monocular Visual Loss:

Step 1: Check for RAPD — presence confirms optic nerve localization
Step 2: Assess for pain — pain with eye movement suggests optic neuritis; painless suggests ischemic or compressive
Step 3: Examine the disc — edema suggests anterior pathology; normal disc suggests retrobulbar
Step 4: Consider age — young patient (under 50) think demyelinating; older patient think ischemic or compressive

Probability	Condition	Approximate Frequency	Key Distinguishing Features
COMMON	Optic neuritis (demyelinating)	Most common cause in patients under 50	Pain with eye movement (90%), progressive over days then stabilizes, central scotoma, dyschromatopsia, RAPD; disc normal (retrobulbar) or mildly swollen
COMMON	Non-arteritic anterior ischemic optic neuropathy (delayed presentation)	Most common optic neuropathy over age 50	Painless, altitudinal defect, disc edema with hemorrhages; “disc at risk” in fellow eye
LESS COMMON	Compressive optic neuropathy	5 to 10% of subacute cases	Slowly progressive, may have proptosis, ophthalmoplegia; causes include meningioma, pituitary adenoma, aneurysm, thyroid eye disease
LESS COMMON	Neuromyelitis optica spectrum disorder	Rare but important to recognize	Severe vision loss (often worse than multiple sclerosis-related optic neuritis), bilateral or recurrent, poor recovery; aquaporin-4 antibody positive
LESS COMMON	Myelin oligodendrocyte glycoprotein antibody-associated disease	Increasingly recognized	Bilateral optic neuritis common, disc edema prominent, good recovery but relapses common
UNCOMMON	Infectious optic neuritis	Rare in immunocompetent	Syphilis, Lyme disease, tuberculosis, cryptococcus, toxoplasmosis; consider in immunocompromised or atypical features
UNCOMMON	Toxic or nutritional optic neuropathy	Rare	Bilateral, symmetric, painless; history of ethambutol, methanol, alcohol abuse, malnutrition (vitamin B12, folate deficiency)
UNCOMMON	Leber hereditary optic neuropathy	Rare (1 in 50,000)	Young men, sequential bilateral involvement over weeks to months, maternal inheritance, characteristic fundus appearance

Acute Binocular Visual Loss

Binocular Visual Loss = Posterior to Chiasm Until Proven Otherwise

When both eyes are affected simultaneously, the lesion is almost always at or posterior to the optic chiasm. This requires urgent neuroimaging. Consider:

Bilateral occipital stroke — “top of the basilar” syndrome; may have cortical blindness with denial (Anton syndrome)
Pituitary apoplexy — severe headache, bitemporal hemianopia, ophthalmoplegia
Posterior reversible encephalopathy syndrome — hypertension, immunosuppression, eclampsia; bilateral occipital edema on MRI
Bilateral anterior ischemic optic neuropathy — rare but occurs with giant cell arteritis or severe hypotension

Condition	Mechanism	Key Features	Urgent Action
Bilateral occipital stroke	Posterior cerebral artery occlusion bilaterally (basilar tip embolus or thrombosis)	Cortical blindness (no light perception), normal pupil responses, may deny blindness (Anton syndrome)	Emergent CT/MRI, stroke protocol, consider thrombolysis if within window
Pituitary apoplexy	Hemorrhage or infarction of pituitary adenoma with acute expansion	Thunderclap headache, bitemporal hemianopia, ophthalmoplegia, altered consciousness	Emergent MRI, neurosurgical consultation, high-dose corticosteroids
Posterior reversible encephalopathy syndrome	Vasogenic edema from endothelial dysfunction (hypertension, toxins, eclampsia)	Headache, confusion, seizures, bilateral vision loss; MRI shows posterior white matter edema	Blood pressure control, remove offending agent, supportive care; usually reversible
Bilateral giant cell arteritis	Sequential or simultaneous arteritic anterior ischemic optic neuropathy	Age over 50, may have systemic symptoms, bilateral disc pallor or edema	Immediate high-dose intravenous corticosteroids, temporal artery biopsy
Cerebral venous thrombosis with bilateral involvement	Venous congestion leading to bilateral hemispheric dysfunction	Headache, papilledema, may have seizures, focal deficits	MR venography, anticoagulation

Anatomical Approach to Differential Diagnosis

Ocular Media and Retina

Corneal edema (acute glaucoma)

Cataract (usually gradual)

Vitreous hemorrhage

Retinal detachment

Central retinal artery occlusion

Central retinal vein occlusion

Macular pathology

Optic Nerve

Optic neuritis

Anterior ischemic optic neuropathy

Posterior ischemic optic neuropathy

Compressive optic neuropathy

Toxic/nutritional optic neuropathy

Infiltrative optic neuropathy

Traumatic optic neuropathy

Optic Chiasm

Pituitary adenoma

Pituitary apoplexy

Craniopharyngioma

Meningioma

Aneurysm compression

Demyelination

Infiltrative disease

Retrochiasmal Pathway

Occipital stroke

Posterior reversible encephalopathy syndrome

Tumor (optic radiations, occipital lobe)

Hemorrhage

Abscess

Demyelinating lesions

Posterior cortical atrophy

Transient Visual Loss (Lasting Seconds to Minutes)

Pattern	Duration	Most Likely Cause	Workup Priority
Monocular blackout, seconds to minutes	Typically 2 to 30 minutes	Amaurosis fugax (retinal transient ischemic attack) from carotid stenosis or cardiac embolism	Urgent: carotid imaging, echocardiogram, consider admission; 8% annual stroke risk
Monocular graying with position change	Seconds	Papilledema-related transient visual obscurations	MRI brain and MR venography to exclude mass and venous thrombosis; lumbar puncture for opening pressure
Binocular positive phenomena (zigzags, shimmering)	15 to 30 minutes	Migraine with visual aura	Usually benign if followed by headache; atypical features require imaging
Binocular blackout with vertigo	Minutes	Vertebrobasilar transient ischemic attack	Urgent: MRI with diffusion-weighted imaging, MR angiography of posterior circulation
Monocular vision loss with bright light exposure	Minutes after bright light	Ocular ischemic syndrome (carotid stenosis causing chronic ocular hypoperfusion)	Carotid Doppler ultrasound; may need revascularization

Drug-Induced Visual Loss

Drug or Drug Class	Mechanism	Characteristics	Reversibility
Ethambutol	Mitochondrial toxicity to retinal ganglion cells	Bilateral central scotomas, dyschromatopsia (red-green), dose-dependent (greater than 15 mg/kg/day)	Usually reversible if detected early and drug stopped; may be permanent if prolonged
Amiodarone	Optic neuropathy (mechanism unclear); also causes corneal deposits	Bilateral progressive vision loss, disc edema; corneal verticillata (common but not vision-threatening)	Variable; may progress despite stopping drug
Phosphodiesterase-5 inhibitors (sildenafil, tadalafil)	May precipitate non-arteritic anterior ischemic optic neuropathy in predisposed individuals	Acute painless monocular vision loss, altitudinal defect, disc edema	Not reversible; contraindicated if prior non-arteritic anterior ischemic optic neuropathy
Vigabatrin	GABA transaminase inhibition causing retinal toxicity	Bilateral concentric visual field constriction; central acuity preserved until late	Irreversible; requires regular visual field monitoring
Hydroxychloroquine	Accumulates in retinal pigment epithelium, causing macular toxicity	Bull’s eye maculopathy, paracentral scotomas; risk increases after 5 years and cumulative dose greater than 1000 g	Irreversible; may progress after stopping; requires annual screening
Topiramate	Ciliary body edema causing acute angle closure	Acute bilateral vision loss, eye pain, myopic shift; occurs within first month of treatment	Reversible within days of stopping drug; does not respond to laser iridotomy
Methanol	Formic acid (metabolite) causes mitochondrial toxicity to optic nerve	Bilateral severe vision loss, may have complete blindness; associated with metabolic acidosis	Often irreversible; fomepizole is antidote; hemodialysis for severe cases
Linezolid	Mitochondrial toxicity with prolonged use (greater than 28 days)	Bilateral optic neuropathy similar to ethambutol	Usually reversible if caught early
Checkpoint inhibitors (pembrolizumab, nivolumab)	Immune-mediated optic neuritis	Unilateral or bilateral optic neuritis; may occur weeks to months after starting therapy	Often responsive to corticosteroids; may require holding immunotherapy

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Immediate Next Step
Cherry red spot on fundus	Central retinal artery occlusion	Ocular massage, consider intra-arterial thrombolysis if within 4 to 6 hours; rule out giant cell arteritis
Chalky white disc edema in patient over 50	Arteritic anterior ischemic optic neuropathy (giant cell arteritis)	Immediate intravenous methylprednisolone; erythrocyte sedimentation rate, C-reactive protein; temporal artery biopsy
Pain with eye movement in young patient	Optic neuritis	MRI brain and orbits with contrast; consider lumbar puncture for multiple sclerosis workup
Altitudinal field defect with disc edema	Anterior ischemic optic neuropathy	Erythrocyte sedimentation rate and C-reactive protein to rule out giant cell arteritis; assess vascular risk factors
Bitemporal hemianopia	Chiasmal compression (pituitary adenoma)	MRI brain with pituitary protocol; pituitary hormone panel
Homonymous hemianopia with normal fundi	Retrochiasmal lesion (stroke, tumor)	Emergent MRI brain; if stroke suspected, follow stroke protocol
Rock-hard eye with mid-dilated pupil	Acute angle-closure glaucoma	Immediate intraocular pressure-lowering treatment; ophthalmology emergency consultation
Flashes then floaters then “curtain”	Retinal detachment	Urgent dilated fundus examination; ophthalmology consultation for surgical repair
Transient monocular blackout lasting minutes	Amaurosis fugax (embolic transient ischemic attack)	Urgent carotid imaging; echocardiogram; consider admission for stroke workup
Bilateral vision loss with severe headache and ophthalmoplegia	Pituitary apoplexy	Emergent MRI; neurosurgical consultation; high-dose corticosteroids
Cortical blindness with intact pupil responses	Bilateral occipital stroke	Emergent MRI with diffusion-weighted imaging; stroke protocol
Vision loss with hypertension, confusion, seizures	Posterior reversible encephalopathy syndrome	Blood pressure control; MRI brain; identify and remove precipitant

6. Diagnostic Investigations

A stepwise, targeted approach guided by clinical suspicion

Baseline Investigations for All Patients with Acute or Subacute Visual Loss

Investigation	Purpose	What to Look For	Practical Points
Visual acuity (each eye)	Quantify vision loss and monitor progression	Snellen or LogMAR acuity; pinhole acuity to assess refractive component	Document with and without correction; pinhole improvement suggests refractive error, not neurological cause
Pupillary examination with RAPD assessment	Localize lesion to optic nerve versus retina/media	Presence of relative afferent pupillary defect indicates optic nerve dysfunction	Use dim ambient light; swing flashlight every 2 to 3 seconds; even subtle RAPD is significant
Visual field testing (confrontation at minimum)	Pattern of field loss localizes lesion along visual pathway	Central scotoma, altitudinal defect, hemianopia, quadrantanopia	Formal perimetry (Humphrey or Goldmann) if bedside testing abnormal or diagnosis unclear
Dilated fundus examination	Visualize optic disc, retina, and vessels	Disc edema, pallor, cupping; retinal hemorrhages, detachment, vascular occlusion signs	Do not dilate if acute angle closure suspected or neurological observation required; otherwise essential
Intraocular pressure	Rule out acute glaucoma	Normal 10 to 21 mmHg; greater than 40 mmHg suggests acute angle closure	Tactile assessment (hard eye) is useful if no tonometer available
Erythrocyte sedimentation rate and C-reactive protein	Screen for giant cell arteritis in all patients over age 50	Erythrocyte sedimentation rate greater than 50 mm/hr and/or C-reactive protein greater than 2.5 mg/dL suggests giant cell arteritis	Normal values do not exclude giant cell arteritis (5% have normal inflammatory markers); if clinical suspicion high, treat empirically
Complete blood count	Screen for anemia, infection, hyperviscosity	Severe anemia can worsen ischemic optic neuropathy; elevated white blood cell count suggests infection; very high hematocrit suggests polycythemia	Platelet count useful if considering antiplatelet therapy
Basic metabolic panel and glucose	Assess vascular risk factors and general health	Diabetes (glucose, HbA1c), renal function	Renal function important before contrast imaging

Targeted Investigations by Suspected Etiology

If Suspecting Giant Cell Arteritis

Do Not Delay Treatment for Testing

If giant cell arteritis is clinically suspected, start high-dose corticosteroids immediately. Temporal artery biopsy remains positive for up to 2 weeks after starting steroids.

First-Line Tests

Erythrocyte sedimentation rate: Typically greater than 50 mm/hr (often greater than 100 mm/hr); use age-adjusted formula (age/2 for men, [age+10]/2 for women)
C-reactive protein: Often greater than 2.5 mg/dL; may be more sensitive than erythrocyte sedimentation rate
Complete blood count: Normocytic anemia and thrombocytosis are common
Liver function tests: Elevated alkaline phosphatase in 25% of cases

Confirmatory Tests

Temporal artery biopsy: Gold standard; obtain at least 2 cm length; skip lesions may cause false negatives; consider bilateral biopsy
Temporal artery ultrasound: “Halo sign” (hypoechoic ring around artery) is suggestive; operator-dependent; increasingly used for rapid assessment
MRI of cranial arteries: May show vessel wall enhancement in large vessel vasculitis
PET-CT: Can detect large vessel involvement (aortitis) in cases with negative biopsy

If Suspecting Optic Neuritis

First-Line Tests

MRI brain with gadolinium: Look for demyelinating lesions; 50% of optic neuritis patients have white matter lesions suggestive of multiple sclerosis
MRI orbits with fat suppression: Shows optic nerve enhancement and/or swelling; confirms diagnosis
Optical coherence tomography: Measures retinal nerve fiber layer thickness; useful for monitoring and prognosis

Second-Line and Specialty Tests

Lumbar puncture: Oligoclonal bands present in 60 to 70% of multiple sclerosis; cell count and protein for infectious or inflammatory causes
Aquaporin-4 antibody (anti-AQP4/NMO-IgG): Order if severe vision loss, bilateral involvement, poor recovery, or recurrent episodes
Myelin oligodendrocyte glycoprotein antibody (anti-MOG): Order if disc edema prominent, bilateral, or atypical for multiple sclerosis
Visual evoked potentials: Prolonged P100 latency confirms optic nerve conduction delay; useful if diagnosis uncertain

If Suspecting Retinal Vascular Occlusion

Embolic Source Evaluation

Carotid Doppler ultrasound: Screen for carotid stenosis (greater than 50% stenosis is significant); order urgently for central retinal artery occlusion and amaurosis fugax
Transthoracic echocardiogram: Evaluate for cardiac source of embolism (valvular disease, thrombus, patent foramen ovale)
ECG and telemetry: Screen for atrial fibrillation
CT angiography or MR angiography of head and neck: Comprehensive evaluation of cervicocephalic vessels

Vascular Risk Assessment and Additional Testing

Fasting lipid panel: Hyperlipidemia is modifiable risk factor
HbA1c: Screen for diabetes
Erythrocyte sedimentation rate and C-reactive protein: Rule out giant cell arteritis in patients over 50
Hypercoagulability workup: Consider in young patients or those without traditional risk factors (factor V Leiden, prothrombin gene mutation, antiphospholipid antibodies, protein C and S, antithrombin III)
Fluorescein angiography: Confirms diagnosis, identifies extent of non-perfusion, guides treatment

If Suspecting Compressive or Infiltrative Optic Neuropathy

Imaging

MRI brain and orbits with contrast: Essential; evaluate optic nerves, chiasm, and parasellar region
CT orbits: If MRI contraindicated; better for bony detail (orbital apex, optic canal)
MRI pituitary protocol: If bitemporal hemianopia or pituitary dysfunction suspected
CT angiography or MR angiography: If aneurysm suspected as cause of compression

Additional Studies

Pituitary hormone panel: Prolactin, thyroid function, cortisol, growth hormone, gonadotropins if pituitary lesion identified
Chest CT: If sarcoidosis or malignancy suspected
Serum ACE level: Elevated in sarcoidosis (sensitivity approximately 60%)
Lumbar puncture: If infiltrative process suspected (lymphoma, leukemia, carcinomatous meningitis)

If Suspecting Posterior Pathway Lesion (Stroke, Tumor)

Emergent Imaging

CT head without contrast: First-line for acute stroke; rules out hemorrhage; may miss early ischemia and posterior fossa lesions
MRI brain with diffusion-weighted imaging: Most sensitive for acute ischemic stroke; essential for posterior circulation strokes
CT angiography or MR angiography: Evaluate for large vessel occlusion, dissection, or stenosis
CT perfusion: May identify penumbra in acute stroke

Stroke Workup

Echocardiogram: Transthoracic initially; transesophageal if higher yield needed
Cardiac telemetry: Minimum 24 to 48 hours; extended monitoring for cryptogenic stroke
Carotid and vertebral artery imaging: Doppler ultrasound, CT angiography, or MR angiography
Hypercoagulability testing: In young patients or cryptogenic stroke

Optical Coherence Tomography in Visual Loss

When Optical Coherence Tomography Is Most Useful

Optical coherence tomography (OCT) provides high-resolution cross-sectional imaging of the retina and optic nerve head. It is increasingly essential in the evaluation of visual loss:

Retinal nerve fiber layer thickness: Thickening indicates acute disc edema; thinning indicates prior optic nerve damage (atrophy)
Ganglion cell layer analysis: Thinning indicates retrograde degeneration from optic nerve or retrochiasmal lesions
Distinguishing papilledema from pseudopapilledema: OCT can identify buried drusen and true nerve fiber layer edema
Monitoring optic neuritis: Retinal nerve fiber layer thinning greater than 75 microns at 6 months predicts worse visual outcome
Macular pathology: Identifies macular edema, subretinal fluid, drusen, epiretinal membrane

Neuroimaging Selection Guide

Clinical Scenario	Recommended Imaging	What to Request	Key Findings to Look For
Optic neuritis (typical)	MRI brain and orbits	With gadolinium; fat-suppressed sequences for orbits	Optic nerve enhancement; periventricular white matter lesions (multiple sclerosis); number of lesions predicts multiple sclerosis risk
Suspected compressive lesion	MRI brain and orbits	With gadolinium; thin cuts through orbits and parasellar region	Orbital mass, optic nerve sheath meningioma, pituitary adenoma, aneurysm
Bitemporal hemianopia	MRI pituitary protocol	Thin coronal and sagittal cuts through sella	Pituitary adenoma, craniopharyngioma, meningioma, aneurysm
Homonymous hemianopia (acute)	CT head (emergent), then MRI	CT without contrast first; MRI with diffusion-weighted imaging	Stroke (ischemic or hemorrhagic), mass lesion
Papilledema	MRI brain with MR venography	Rule out mass lesion and venous sinus thrombosis before lumbar puncture	Mass lesion, hydrocephalus, venous thrombosis, empty sella (in idiopathic intracranial hypertension)
Posterior reversible encephalopathy syndrome suspected	MRI brain	FLAIR and diffusion-weighted imaging sequences	Bilateral posterior white matter edema (FLAIR hyperintensity without diffusion restriction)
Orbital pathology (proptosis, pain)	CT orbits (for bone) and/or MRI orbits (for soft tissue)	CT with contrast for infection/inflammation; MRI for tumor characterization	Orbital mass, thyroid eye disease, orbital cellulitis, cavernous sinus involvement

Laboratory Testing by Clinical Scenario

Clinical Scenario	Essential Labs	Consider Adding
Any patient over 50 with acute optic neuropathy	Erythrocyte sedimentation rate, C-reactive protein, complete blood count	Liver function tests (alkaline phosphatase elevated in giant cell arteritis)
Optic neuritis workup	MRI brain, consider lumbar puncture	Aquaporin-4 antibody, myelin oligodendrocyte glycoprotein antibody (especially if atypical, bilateral, or severe)
Retinal vascular occlusion in young patient	Complete blood count, lipid panel, HbA1c, erythrocyte sedimentation rate	Antiphospholipid antibodies, factor V Leiden, prothrombin gene mutation, homocysteine
Bilateral optic neuropathy	Vitamin B12, folate, complete blood count	Thiamine, copper, methylmalonic acid, genetic testing for Leber hereditary optic neuropathy
Suspected infectious optic neuritis	Syphilis serology (RPR, treponemal antibody), HIV	Lyme serology, tuberculosis testing (QuantiFERON), toxoplasma serology, lumbar puncture
Suspected sarcoidosis	ACE level, chest radiograph	Chest CT, gallium scan or PET-CT, lumbar puncture, tissue biopsy

Empiric Treatment Trials as Diagnostic Tools

When Empiric Treatment Is Both Therapeutic and Diagnostic

In some situations, response to treatment helps confirm the diagnosis:

Giant cell arteritis: If clinical suspicion is high and inflammatory markers are elevated, start high-dose corticosteroids immediately. Rapid improvement in systemic symptoms (headache, malaise) supports the diagnosis. Visual loss, unfortunately, is often irreversible even with treatment.
Optic neuritis: Intravenous methylprednisolone (1 g daily for 3 to 5 days) speeds recovery. Improvement within days supports inflammatory etiology. Note: oral prednisone alone (without IV induction) is NOT recommended due to increased relapse risk.
Acute angle-closure glaucoma: Response to pressure-lowering medications (topical and systemic) confirms the diagnosis and is therapeutic.
Posterior reversible encephalopathy syndrome: Blood pressure control and removal of offending agent leads to clinical and radiographic improvement within days to weeks, confirming the diagnosis.

Investigation Algorithm Summary

Stepwise Approach to Investigating Visual Loss:

All patients: Visual acuity, pupil examination (RAPD), visual fields, dilated fundus examination, intraocular pressure
All patients over 50 with optic neuropathy: Erythrocyte sedimentation rate, C-reactive protein, complete blood count — treat empirically for giant cell arteritis if positive
Monocular with RAPD and disc edema: Consider ischemic versus inflammatory optic neuropathy; age guides workup (giant cell arteritis workup if over 50; MRI and demyelinating workup if under 50)
Monocular with RAPD and normal disc: Retrobulbar optic neuritis or early ischemic optic neuropathy; MRI brain and orbits with contrast
Retinal findings (cherry red spot, hemorrhages): Vascular occlusion workup — carotid imaging, echocardiogram, cardiac rhythm monitoring
Binocular visual loss: Emergent neuroimaging (MRI preferred) to evaluate chiasm and retrochiasmal pathway
Homonymous defect: Stroke protocol if acute; MRI brain for all to characterize lesion

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways for visual loss

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Sudden painless monocular blindness (minutes ago)	EMERGENT (minutes)	Central retinal artery occlusion until proven otherwise; ocular massage, lower intraocular pressure, consider intra-arterial thrombolysis; 90-minute window for potential salvage
Age over 50 with vision loss + new headache or jaw claudication	EMERGENT (hours)	Giant cell arteritis until proven otherwise; start intravenous methylprednisolone 1 g immediately; do not wait for lab results or biopsy
Severe eye pain with nausea, halos, red eye	EMERGENT (hours)	Acute angle-closure glaucoma; check intraocular pressure; start topical and systemic pressure-lowering agents; urgent ophthalmology consultation
Flashes, floaters, then “curtain” over vision	EMERGENT (hours)	Retinal detachment; urgent dilated fundus examination; if macula attached, surgical repair within 24 hours
Bilateral vision loss with severe headache	EMERGENT (hours)	Pituitary apoplexy or bilateral stroke; emergent neuroimaging; neurosurgical consultation if apoplexy confirmed
Transient monocular vision loss (resolved)	URGENT (24-48 hours)	Amaurosis fugax = retinal transient ischemic attack; urgent carotid imaging, echocardiogram, cardiac monitoring; high stroke risk
Progressive vision loss over days with eye pain	URGENT (days)	Optic neuritis likely; MRI brain and orbits within 1 week; consider intravenous corticosteroids if severe
Homonymous hemianopia discovered incidentally	URGENT (days)	Retrochiasmal lesion; MRI brain to characterize; if stroke, initiate secondary prevention
Gradual progressive vision loss over weeks to months	ROUTINE (weeks)	Compressive lesion, chronic glaucoma, or degenerative process; comprehensive workup including neuroimaging

Step 2: Classify by Laterality

Monocular Visual Loss

Localization: Anterior to optic chiasm (eye or optic nerve)

Key question: Is there a relative afferent pupillary defect?

RAPD present → Optic nerve pathology
RAPD absent → Media opacity, retinal, or macular pathology (or functional)

Proceed to Algorithm A or B based on RAPD

Binocular Visual Loss

Localization: At or posterior to optic chiasm

Key question: What is the visual field pattern?

Bitemporal hemianopia → Chiasmal lesion
Homonymous hemianopia → Retrochiasmal lesion
Complete bilateral blindness → Bilateral occipital or bilateral optic nerve

Proceed to Algorithm C

Step 3: Follow the Appropriate Algorithm

Algorithm A: Monocular Visual Loss WITH Relative Afferent Pupillary Defect (Optic Nerve Localization)

Clinical Scenario	Most Likely Diagnosis	Action
Age over 50, painless, disc edema, altitudinal defect	Anterior ischemic optic neuropathy	Stat erythrocyte sedimentation rate and C-reactive protein; if elevated or symptoms of giant cell arteritis, start corticosteroids immediately
Age over 50, painless, disc edema, headache or jaw claudication	Arteritic anterior ischemic optic neuropathy (giant cell arteritis)	Intravenous methylprednisolone 1 g now; temporal artery biopsy within 2 weeks
Age under 50, painful eye movements, disc normal or mildly swollen	Optic neuritis	MRI brain and orbits with contrast; if demyelinating lesions, discuss multiple sclerosis risk; consider intravenous methylprednisolone
Severe vision loss, poor recovery expected, bilateral or recurrent	Neuromyelitis optica spectrum disorder or myelin oligodendrocyte glycoprotein antibody-associated disease	Check aquaporin-4 antibody and myelin oligodendrocyte glycoprotein antibody; high-dose corticosteroids; consider plasma exchange if no response
Progressive over weeks, proptosis or ophthalmoplegia present	Compressive optic neuropathy	MRI orbits and brain with contrast; identify mass (meningioma, pituitary adenoma, aneurysm); neurosurgical or neuro-ophthalmology referral
Bilateral, symmetric, painless, history of ethambutol or alcohol	Toxic or nutritional optic neuropathy	Stop offending agent; check vitamin B12, folate, thiamine; supplement as needed

Algorithm B: Monocular Visual Loss WITHOUT Relative Afferent Pupillary Defect (Ocular or Macular Localization)

Clinical Scenario	Most Likely Diagnosis	Action
Sudden, painless, cherry red spot visible	Central retinal artery occlusion	Emergent: ocular massage, lower intraocular pressure; rule out giant cell arteritis; stroke workup (carotid, cardiac)
Sudden, painless, “blood and thunder” fundus	Central retinal vein occlusion	Assess for ischemic versus non-ischemic type; screen for vascular risk factors; ophthalmology follow-up for neovascularization
Flashes, floaters, curtain, elevated retina on exam	Retinal detachment	Urgent ophthalmology referral; surgical repair within 24 hours if macula attached
Severe eye pain, rock-hard globe, mid-dilated pupil	Acute angle-closure glaucoma	Topical pressure-lowering drops, acetazolamide, mannitol if needed; urgent laser peripheral iridotomy
Sudden floaters and hazy vision, poor fundus view	Vitreous hemorrhage	B-scan ultrasound to rule out retinal detachment; identify cause (diabetes, tear); ophthalmology referral
Central vision loss, metamorphopsia, normal pupil and disc	Macular pathology (age-related macular degeneration, central serous retinopathy, macular hole)	Optical coherence tomography; ophthalmology referral; treatment depends on specific diagnosis
Reported severe vision loss, but normal examination and normal investigations	Functional (non-organic) visual loss	Confirm with special tests (optokinetic drum, fogging); reassurance; consider psychological support

Algorithm C: Binocular Visual Loss (Chiasmal or Retrochiasmal Localization)

Clinical Scenario	Most Likely Diagnosis	Action
Bitemporal hemianopia, gradual onset	Pituitary adenoma or other parasellar mass	MRI pituitary protocol; pituitary hormone panel; neurosurgical consultation
Bitemporal hemianopia, sudden with severe headache	Pituitary apoplexy	Emergent MRI; high-dose corticosteroids; urgent neurosurgical evaluation for possible decompression
Homonymous hemianopia, sudden onset	Occipital or temporal-parietal stroke	Stroke protocol; CT head emergently, MRI with diffusion-weighted imaging; thrombolysis if within window; secondary prevention
Homonymous hemianopia with hemisensory loss or hemiparesis	Middle cerebral artery territory stroke or mass	Emergent neuroimaging; stroke protocol if acute
Complete cortical blindness, normal pupil responses	Bilateral occipital stroke (“top of basilar”)	Emergent MRI; patient may deny blindness (Anton syndrome); posterior circulation stroke workup
Bilateral vision loss with hypertension, confusion, seizures	Posterior reversible encephalopathy syndrome	Blood pressure control; MRI shows posterior white matter edema; remove precipitant; usually reversible
Homonymous hemianopia, subacute, with headache	Mass lesion (tumor, abscess) or venous thrombosis	MRI brain with contrast; MR venography if thrombosis suspected

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Patient has central retinal artery occlusion and it has been 2 hours	Still attempt ocular massage, lower intraocular pressure, high-flow oxygen; some centers offer intra-arterial thrombolysis up to 6 hours	Complete stroke workup regardless of visual outcome; rule out giant cell arteritis
Erythrocyte sedimentation rate is normal but I still suspect giant cell arteritis	Erythrocyte sedimentation rate and C-reactive protein are normal in 5% of biopsy-proven giant cell arteritis; if clinical suspicion is high, start corticosteroids anyway	Proceed with temporal artery biopsy; consider temporal artery ultrasound or additional imaging
Patient with optic neuritis—should I give steroids?	Intravenous methylprednisolone speeds recovery but does not change final visual outcome; offer if patient wants faster recovery or vision loss is severe	MRI brain to assess multiple sclerosis risk; discuss disease-modifying therapy if high-risk
Young patient with central retinal artery occlusion—what additional workup?	Standard stroke workup plus hypercoagulability panel (antiphospholipid antibodies, factor V Leiden, prothrombin mutation, protein C and S)	Echocardiogram with bubble study to evaluate for patent foramen ovale
Patient has homonymous hemianopia but is unaware of it	This is common with occipital strokes (visual anosognosia); patient may bump into objects on affected side	Formal visual field testing; driving restriction; occupational therapy evaluation
Retinal detachment is found but macula is already detached	Urgent (not emergent) surgical repair; visual prognosis is worse but surgery still indicated	Ophthalmology should repair within 1 week; outcomes depend on duration of macular detachment
Patient with disc edema—is it papilledema or papillitis?	Papilledema is bilateral, visual acuity preserved, and due to elevated intracranial pressure; papillitis is usually unilateral with decreased acuity	If bilateral disc edema with preserved acuity, obtain MRI and MR venography before lumbar puncture
Optic neuritis patient has aquaporin-4 antibody positive	This is neuromyelitis optica spectrum disorder, not multiple sclerosis; different treatment and prognosis	Avoid interferon-beta (may worsen neuromyelitis optica); start immunosuppression (rituximab, eculizumab, or others)

Troubleshooting Unexplained or Refractory Visual Loss

When the Diagnosis Remains Unclear

Re-examine the patient: Subtle RAPD or visual field defect may become apparent; repeat dilated fundus examination
Obtain optical coherence tomography: May reveal subclinical retinal nerve fiber layer thinning or macular pathology not visible on funduscopy
Consider neuroimaging if not done: MRI brain and orbits with contrast can reveal compressive, infiltrative, or inflammatory lesions
Review medications: Drug-induced optic neuropathy may be overlooked (ethambutol, amiodarone, and others)
Check for nutritional deficiencies: Vitamin B12, folate, thiamine, and copper deficiency can cause bilateral optic neuropathy
Consider infectious etiologies: Syphilis serology, Lyme titers, tuberculosis testing, especially if immunocompromised
Think about hereditary causes: Leber hereditary optic neuropathy in young patients with bilateral sequential involvement
Evaluate for functional visual loss: If examination and investigations are normal, special tests can confirm non-organic etiology
Refer to neuro-ophthalmology: Complex cases benefit from subspecialty evaluation

Time-Critical Conditions: Treatment Windows

Condition	Treatment Window	Consequence of Delay
Central retinal artery occlusion	90 to 120 minutes (similar to stroke)	Irreversible retinal infarction and permanent monocular blindness
Giant cell arteritis (arteritic anterior ischemic optic neuropathy)	Hours to days before fellow eye involvement	50% risk of bilateral blindness within 1 to 2 weeks without treatment
Acute angle-closure glaucoma	Hours	Permanent optic nerve damage from sustained elevated pressure
Retinal detachment (macula-on)	24 hours	Macula detachment leads to worse visual outcome even with successful repair
Pituitary apoplexy with visual loss	Days (earlier is better)	Permanent optic nerve damage from compression; endocrine crisis
Occipital stroke (thrombolysis candidate)	4.5 hours for intravenous thrombolysis	Permanent homonymous hemianopia

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

The RAPD is your best friend: A relative afferent pupillary defect localizes the lesion to the optic nerve with high specificity. Its presence with visual loss means optic nerve pathology; its absence with monocular visual loss suggests the problem is anterior to the ganglion cells (media, retina, macula) or is functional.

Age 50 is the magic number: In patients over 50 with acute optic neuropathy, always consider giant cell arteritis. Check erythrocyte sedimentation rate and C-reactive protein on everyone, but treat empirically if clinical suspicion is high—do not wait for results.

Central retinal artery occlusion is a stroke equivalent: These patients have the same embolic risk factors as stroke patients and deserve the same urgent workup—carotid imaging, echocardiogram, and cardiac rhythm monitoring. Their risk of subsequent stroke is substantial.

Pain with eye movement is the hallmark of optic neuritis: Approximately 90% of patients with optic neuritis have pain exacerbated by eye movement. This helps distinguish it from ischemic optic neuropathy, which is painless.

The disc can be normal in optic nerve disease: In retrobulbar optic neuritis, the disc appears normal initially because the inflammation is behind the eye. “The patient sees nothing, and the doctor sees nothing.” A normal fundus does not exclude optic nerve pathology.

Homonymous means posterior: A homonymous visual field defect (same side affected in both eyes) always localizes posterior to the optic chiasm. The more congruous (identical) the defect in both eyes, the more posterior the lesion.

Ask about the sequence in retinal detachment: Photopsias (flashes) first, then floaters, then a “curtain” or shadow. This classic sequence helps distinguish retinal detachment from other causes of acute visual loss.

Temporal artery biopsy stays positive for weeks: Starting corticosteroids for suspected giant cell arteritis does not invalidate the biopsy. Inflammation persists for up to 2 weeks after treatment initiation, so never delay treatment while arranging biopsy.

Critical Pitfalls to Avoid

Missing giant cell arteritis because inflammatory markers are normal: Up to 5% of biopsy-proven giant cell arteritis cases have normal erythrocyte sedimentation rate and C-reactive protein. If the clinical picture is suggestive (age over 50, new headache, jaw claudication, scalp tenderness, polymyalgia symptoms), treat empirically.

Assuming a normal fundus means no serious pathology: Retrobulbar optic neuritis, early central retinal artery occlusion, posterior ischemic optic neuropathy, and all retrochiasmal lesions can present with a completely normal fundus. History and examination localize the lesion; imaging confirms it.

Forgetting to check the fellow eye in non-arteritic anterior ischemic optic neuropathy: The fellow eye often has a “disc at risk” (small cup-to-disc ratio). Patients have a 15% risk of fellow eye involvement over 5 years. Documenting the fellow eye helps with counseling and monitoring.

Treating optic neuritis with oral prednisone alone: The Optic Neuritis Treatment Trial showed that oral prednisone alone (without intravenous induction) increased the risk of recurrent optic neuritis. If treating, use intravenous methylprednisolone first, then oral taper.

Dilating the pupil when acute angle-closure glaucoma is suspected: Dilation can worsen angle closure and further elevate intraocular pressure. Check pressure and examine the anterior chamber before dilating any patient with acute painful vision loss and red eye.

Attributing visual loss to cataract without complete examination: Cataract typically causes gradual, not acute, visual loss. If a patient presents with sudden vision loss and has a cataract, look for other causes—the cataract may be incidental.

Missing the diagnosis of neuromyelitis optica spectrum disorder: If optic neuritis is severe, bilateral, or poorly recovering, test for aquaporin-4 antibody. Neuromyelitis optica spectrum disorder requires different treatment than multiple sclerosis, and some multiple sclerosis therapies can worsen it.

Delaying stroke workup after central retinal artery occlusion: Central retinal artery occlusion is a stroke equivalent with significant risk of subsequent cerebrovascular events. Complete the embolic workup urgently, even if the eye itself cannot be salvaged.

Key Takeaways

Acute visual loss is a medical emergency until proven otherwise—time-sensitive conditions like central retinal artery occlusion and giant cell arteritis can cause irreversible blindness within hours.
The relative afferent pupillary defect (RAPD) is the most important bedside test for localizing visual loss to the optic nerve versus other structures.
Monocular visual loss localizes anterior to the optic chiasm (eye or optic nerve); binocular visual loss localizes at or posterior to the chiasm.
In all patients over 50 with acute optic neuropathy, giant cell arteritis must be excluded with inflammatory markers—but do not let normal results delay treatment if clinical suspicion is high.
Central retinal artery occlusion has a 90-minute treatment window similar to acute stroke and requires the same embolic workup as cerebral ischemia.
Optic neuritis is characterized by pain with eye movement, subacute progression, and often normal disc appearance (retrobulbar); MRI determines multiple sclerosis risk.
Acute angle-closure glaucoma presents with severe eye pain, nausea, halos, and a rock-hard eye—measure intraocular pressure before dilating any patient with painful acute vision loss.
A normal fundus examination does not exclude serious pathology—retrobulbar optic neuritis, early central retinal artery occlusion, and all retrochiasmal lesions can have normal fundi.
Homonymous visual field defects indicate lesions posterior to the optic chiasm and require neuroimaging to identify stroke, tumor, or other structural pathology.
When in doubt, image the brain and orbits—MRI with contrast can reveal inflammatory, compressive, and ischemic lesions that are not apparent on clinical examination alone.

Quick Reference Algorithm

Systematic Approach to Acute and Subacute Visual Loss:

Triage for emergencies: Identify central retinal artery occlusion (90-minute window), giant cell arteritis (same-day steroids), acute angle-closure glaucoma (immediate pressure lowering), and retinal detachment (24-hour surgical repair).
Determine laterality: Monocular = anterior to chiasm; binocular = chiasm or posterior.
Test for RAPD: Present = optic nerve; absent = media, retina, macula, or functional (if monocular) or chiasmal/retrochiasmal (if binocular pattern).
Examine the fundus: Disc edema, pallor, cherry red spot, retinal hemorrhages, and detachment each point to specific diagnoses.
Check inflammatory markers in patients over 50: Erythrocyte sedimentation rate and C-reactive protein to screen for giant cell arteritis.
Image when indicated: MRI brain and orbits for optic nerve and chiasmal lesions; CT or MRI for retrochiasmal lesions; carotid imaging for embolic causes.
Treat time-sensitive conditions immediately: Do not delay treatment for giant cell arteritis, central retinal artery occlusion intervention, or acute glaucoma while awaiting test results.
Complete the workup: Even if the acute threat is addressed, complete the appropriate investigations (stroke workup for vascular occlusions, multiple sclerosis workup for optic neuritis) to guide long-term management.